Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision label was updated from 3.5.3 to 3.5.4, indicating a newer version of the page. This appears to be a minor metadata update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-05-18T03:52:27.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s site release/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:53:14.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T14:31:05.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Padova, Italy, 35128 was added to the locations list and Padua, Italy, 35128 was removed.
    Difference
    0.0%
    Check dated 2026-04-05T08:04:25.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Location name updated from Napoli, Italy, 80100 to Naples, Italy, 80100; page revision changed from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T02:36:59.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T18:12:19.000Z thumbnail image

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.